Oki Y - Search Results

1

Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.

Wang M, Oki Y, Pro B, Romaguera JE, Rodriguez MA, Samaniego F, McLaughlin P, Hagemeister F, Neelapu S, Copeland A, Samuels BI, Loyer EM, Ji Y, Younes A. Wang M, et al. Among authors: oki y. J Clin Oncol. 2009 Nov 1;27(31):5213-8. doi: 10.1200/JCO.2009.21.8545. Epub 2009 Sep 21. J Clin Oncol. 2009. PMID: 19770379 Clinical Trial.

2

Heat shock protein-based cancer vaccines.

Oki Y, Younes A. Oki Y, et al. Expert Rev Vaccines. 2004 Aug;3(4):403-11. doi: 10.1586/14760584.3.4.403. Expert Rev Vaccines. 2004. PMID: 15270645 Free article. Review.

3

Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma.

Oki Y, McLaughlin P, Pro B, Hagemeister FB, Bleyer A, Loyer E, Younes A. Oki Y, et al. Cancer. 2005 Aug 15;104(4):781-7. doi: 10.1002/cncr.21219. Cancer. 2005. PMID: 15973667 Free article. Clinical Trial.

4

Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma.

Oki Y, McLaughlin P, Fayad LE, Pro B, Mansfield PF, Clayman GL, Medeiros LJ, Kwak LW, Srivastava PK, Younes A. Oki Y, et al. Cancer. 2007 Jan 1;109(1):77-83. doi: 10.1002/cncr.22389. Cancer. 2007. PMID: 17133412 Free article.

5

Prognostic significance of serum B-lymphocyte stimulator in Hodgkin's lymphoma.

Oki Y, Georgakis GV, Migone TS, Kwak LW, Younes A. Oki Y, et al. Haematologica. 2007 Feb;92(2):269-70. doi: 10.3324/haematol.10678. Haematologica. 2007. PMID: 17296586 Free article.

6

Endothelial progenitor cells in non-Hodgkin's lymphoma.

Oki Y, Younes A. Oki Y, et al. Haematologica. 2007 Apr;92(4):433-4. doi: 10.3324/haematol.11367. Haematologica. 2007. PMID: 17488651 Free article. No abstract available.

7

Elevated serum BLyS levels in patients with non-Hodgkin lymphoma.

Oki Y, Georgakis GV, Migone TS, Kwak LW, Younes A. Oki Y, et al. Leuk Lymphoma. 2007 Sep;48(9):1869-71. doi: 10.1080/10428190701549562. Leuk Lymphoma. 2007. PMID: 17786728 No abstract available.

8

Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma.

Oki Y, Pro B, Fayad LE, Romaguera J, Samaniego F, Hagemeister F, Neelapu S, McLaughlin P, Goy A, Younes A. Oki Y, et al. Cancer. 2008 Feb 15;112(4):831-6. doi: 10.1002/cncr.23237. Cancer. 2008. PMID: 18085611 Free article. Clinical Trial.

9

Current role of gemcitabine in the treatment of Hodgkin lymphoma.

Oki Y, Younes A. Oki Y, et al. Leuk Lymphoma. 2008 May;49(5):883-9. doi: 10.1080/10428190801911704. Leuk Lymphoma. 2008. PMID: 18452104 Review.

10

Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomas.

Stewart DJ, Issa JP, Kurzrock R, Nunez MI, Jelinek J, Hong D, Oki Y, Guo Z, Gupta S, Wistuba II. Stewart DJ, et al. Among authors: oki y. Clin Cancer Res. 2009 Jun 1;15(11):3881-8. doi: 10.1158/1078-0432.CCR-08-2196. Epub 2009 May 26. Clin Cancer Res. 2009. PMID: 19470736 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

580 results

Search Page

Filters